本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Rhythm Pharmaceuticals Inc.

65.77
-1.1500-1.72%
盘后65.770.00000.00%16:20 EDT
成交量:62.82万
成交额:4,149.00万
市值:41.84亿
市盈率:-23.33
高:67.44
开:67.05
低:65.61
收:66.92
数据加载中...
2024/08/15

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

重要事件披露

Form 8-K - Current report
2024/06/17

重要事件披露

Form 8-K - Current report
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/30

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership